| Jonathan D Carlson, MD | |
|
105 W 8th Ave, Ste 200, Spokane, WA 99204-2302 | |
| (509) 624-9112 | |
| (509) 624-1087 |
| Full Name | Jonathan D Carlson |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 23 Years |
| Location | 105 W 8th Ave, Spokane, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922219500 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD00049415 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prov Sacred Hrt Med Ctr & Childs Hosp. | Spokane, WA | Hospital |
| Deaconess Medical Center | Spokane, WA | Hospital |
| Providence Holy Family Hospital | Spokane, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Washington | 0345139929 | 687 |
News Archive
A multi-disciplinary group of researchers at the University of Maryland School of Medicine have for the first time determined the genetic makeup of various strains of E. coli, which every year kills hundreds of thousands of people around the world.
During heat waves - when ozone production rises - plants' ozone absorption is curtailed, leaving more pollution in the air, and costing an estimated 460 lives in the UK in the hot summer of 2006.
As health reform heats up, many lawmakers agree that the government should take a larger role in preventing disease. However, the Wall Street Journal reports that "many previous government prevention efforts aimed at costly chronic diseases have had little success in reducing illness or costs."
Talecris Biotherapeutics, Inc. announced today that it was granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the development of an aerosol formulation of Alpha1-Proteinase Inhibitor (Human, A1PI) to treat congenital alpha1-antitrypsin (AAT) deficiency. AAT deficiency is a chronic, hereditary condition that increases the risk of certain diseases, especially emphysema, which typically emerges in the fourth decade of life. Currently, there are no approved, inhaled treatments available for the treatment of AAT deficiency.
Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.
› Verified 5 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194099390 PECOS PAC ID: 0345139929 Enrollment ID: O20040311001453 |
News Archive
A multi-disciplinary group of researchers at the University of Maryland School of Medicine have for the first time determined the genetic makeup of various strains of E. coli, which every year kills hundreds of thousands of people around the world.
During heat waves - when ozone production rises - plants' ozone absorption is curtailed, leaving more pollution in the air, and costing an estimated 460 lives in the UK in the hot summer of 2006.
As health reform heats up, many lawmakers agree that the government should take a larger role in preventing disease. However, the Wall Street Journal reports that "many previous government prevention efforts aimed at costly chronic diseases have had little success in reducing illness or costs."
Talecris Biotherapeutics, Inc. announced today that it was granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the development of an aerosol formulation of Alpha1-Proteinase Inhibitor (Human, A1PI) to treat congenital alpha1-antitrypsin (AAT) deficiency. AAT deficiency is a chronic, hereditary condition that increases the risk of certain diseases, especially emphysema, which typically emerges in the fourth decade of life. Currently, there are no approved, inhaled treatments available for the treatment of AAT deficiency.
Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan D Carlson, MD 105 W 8th Ave, Ste 200, Spokane, WA 99204-2302 Ph: (509) 624-9112 | Jonathan D Carlson, MD 105 W 8th Ave, Ste 200, Spokane, WA 99204-2302 Ph: (509) 624-9112 |
News Archive
A multi-disciplinary group of researchers at the University of Maryland School of Medicine have for the first time determined the genetic makeup of various strains of E. coli, which every year kills hundreds of thousands of people around the world.
During heat waves - when ozone production rises - plants' ozone absorption is curtailed, leaving more pollution in the air, and costing an estimated 460 lives in the UK in the hot summer of 2006.
As health reform heats up, many lawmakers agree that the government should take a larger role in preventing disease. However, the Wall Street Journal reports that "many previous government prevention efforts aimed at costly chronic diseases have had little success in reducing illness or costs."
Talecris Biotherapeutics, Inc. announced today that it was granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the development of an aerosol formulation of Alpha1-Proteinase Inhibitor (Human, A1PI) to treat congenital alpha1-antitrypsin (AAT) deficiency. AAT deficiency is a chronic, hereditary condition that increases the risk of certain diseases, especially emphysema, which typically emerges in the fourth decade of life. Currently, there are no approved, inhaled treatments available for the treatment of AAT deficiency.
Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.
› Verified 5 days ago
Dr. Robert D Martz, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 105 W 8th Ave, Ste 200, Spokane, WA 99204 Phone: 509-624-9112 Fax: 509-624-1087 | |
Alexander R Mackay, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 910 W 5th Ave, Suite 102, Spokane, WA 99204 Phone: 509-228-1000 Fax: 509-252-9300 | |
Dr. Allan Christopher Heller, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 801 W 5th Ave, Suite #525, Spokane, WA 99204 Phone: 509-838-2531 Fax: 509-755-6580 | |
Cynthia A Hahn, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 212 E Central Ave, Suite 360, Spokane, WA 99208 Phone: 509-489-6757 Fax: 509-489-0665 | |
Kathleen L Meyer, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 715 S Cowley St, Suite 210, Spokane, WA 99202 Phone: 509-624-5351 Fax: 509-455-9331 | |
Dr. Meryl A Severson Iii, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 105 W 8th Ave, Suite 200, Spokane, WA 99204 Phone: 509-624-9112 Fax: 509-624-1087 | |
Dr. Yiping Li, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 105 W 8th Ave Ste 200, Spokane, WA 99204 Phone: 509-624-9112 Fax: 509-227-7070 |